Integra LifeSciences has opened its first Asia business office in Shanghai, China.
Integra provides implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care.
It also provides orthopedic products including devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, wound repair, and spine.
Integra CEO Stuart Essig said China’s rapidly growing economy has created a medical device market that presents Integra with major growth opportunities.
Integra vice president JoAnne Harla said initially, they will focus on their neurosurgical business, but their future plans include product introductions in spine and orthobiologics, and an expansion of their existing orthopedics business.